Three-quarters of delta-8 THC products sold in the US are in violation of federal law, according to new lab analysis commissioned by CBD Oracle.
Investigators at FESA Labs analysed the delta-8 and delta-9 THC content of 51 of the most popular hemp-derived delta-8 THC products, finding 76% were above the 0.3% legal limit for delta-9, with an average of 15% less delta-8 than advertised. The average across all products was 6.6%.
Oracle claimed only 16% of companies instituted substantial age verification measures and called for better quality and transparency in the delta-8 industry to improve consumer trust.
Meanwhile, Texas has joined other southern states in the US by banning delta-8 THC amid ongoing safety concerns.
It seems the lone star state quietly outlawed the compound a while back, but published a notice to that effect on the Texas Department of State Health Services website earlier this month.
The update clarifies that while consumable hemp products that do not exceed 0.3% delta-9 THC are legal in the state, “all other forms of THC, including delta-8 in any concentration and delta-9 exceeding 0.3%, are considered Schedule I controlled substances” and are not allowed.
The move comes after the US Food and Drug Administration and the Centres for Disease Control and Prevention issued warnings about delta-8 THC after it emerged more than 100 people in the US had been hospitalised this year having consumed products containing the cannabinoid.
The Society of Cannabis Clinicians in the US has also warned that while there may be no issues with the cannabinoid itself, the conversion of CBD or delta-9 THC into delta-8 can utilise solvents which may be harmful to health.
